Early Adopters Invited by MHRA and NICE to Trial Accelerated Aligned Pathway Six Months Ahead of Schedule

    MHRA and NICE Offer Streamlined Approvals Pathway for Pharmaceutical Companies Friday 10 October, 2025 – Pharmaceutical companies producing qualifying medicines can now take advantage of a streamlined approvals pathway, thanks to the collaborative efforts of the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE).

    Source

    Latest Posts